Pattern of distribution of cells positive for estrogen receptor a and progesterone receptor in relation to proliferating cells in the mammary gland

Breast Cancer Research and Treatment

Volumn 53, Issue 3, 1999, Pages 217-227

  Russo, J ^a   Ao, X ^a   Grill, C ^a,b   Russo, I H ^a  

^a FOX CHASE CANCER CENTER   (United States)

^b RUTGERS UNIVERSITY   (United States)

Author keywords

Breast epithelium; Cell proliferation; Differentiation; Estrogen receptors; Progesterone receptors

Indexed keywords

ESTROGEN RECEPTOR; KI 67 ANTIGEN; PROGESTERONE RECEPTOR;

ADOLESCENT; ADULT; ANIMAL TISSUE; ARTICLE; BREAST CELL; BREAST EPITHELIUM; CELL DIFFERENTIATION; CELL PROLIFERATION; DNA SYNTHESIS; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MAMMARY GLAND; NONHUMAN; NORMAL HUMAN; PRIORITY JOURNAL; RADIORECEPTOR ASSAY; RAT;

ADOLESCENT; ADULT; ANIMALS; BREAST; CELL DIVISION; EPITHELIUM; ESTROGEN RECEPTOR ALPHA; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; KI-67 ANTIGEN; MAMMARY GLANDS, ANIMAL; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, ESTROGEN; RECEPTORS, PROGESTERONE;

EID: 0032925166     PISSN: 01676806     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1006186719322     Document Type: Article

References (60)

1. Russo J, Russo IH: Role of hormones in human breast development: The menopausal breast. In: Progress in the Management of Menopause. Parthenon Publishing, London, 1997, pp 184-193
2. Russo IH, Russo J: Role of hormones in cancer initiation and progression. J Mammary Gland Biol Neoplasia 3: 49-61, 1998
3. Russo J, Russo IH: Role of differentiation in the pathogenesis and prevention of breast cancer. Endocrine Related Cancer 4: 7-21, 1997
4. Calaf G, Alvarado ME, Bonney GE, Get KK, Russo J: Influence of lobular development on breast epithelial cell proliferation and steroid hormone receptor content. Int J Oncol 7: 1285-1288, 1995
5. Lippman ME, Dickson RB, Gelmann EP, Rosen N, Knabbe C, Bates S, Bronzert D, Huff K, Kasid A: Growth regulation of human breast carcinoma occurs through regulated growth factor secretion. J Cell Biochem 35: 1-16, 1987
6. Meyer JS: Cell proliferation in normal human breast ducts, fibroadenomas, and other duct hyperplasias, measured by nuclear labeling with triliated thymidine. Hum Path 8: 67-81, 1977
7. Masters JRW, Drife JO, Scarisbrick JJ: Cyclic variations of DNA synthesis in human breast epithelium. J Natl Cancer Inst 58: 1263-1265, 1977
8. Ferguson DJP, Anderson TJ: Morphologic evaluation of cell turnover in relation to the menstrual cycle in the 'resting' human breast. Br J Cancer 44: 177-181, 1981
9. Anderson TJ, Ferguson DJP, Raab GM: Cell turnover in the 'resting' human breast: Influence of parity, contraceptive pill, age and laterality. Br J Cancer 46: 376-382, 1982
10. Russo J, Russo IH: Estrogens and cell proliferation in the human breast. J Cardiovasc Pharmacol 28: 19-23, 1996
11. Kumar V, Stack GS, Berry M, Jin JR, Chambon P: Funclional domains of the human estrogen receptor. Cell 51: 941-951, 1987
12. King RJB: Effects of steroid hormones and related compounds on gene transcription. Clin Endocrinol 36: 1-14, 1992
13. Solo AM, Sonnenschein C: Cell proliferation of estrogen-sensitive cells: The case for negative control. Endocr Rev 48: 52-58, 1987
14. Huseby RA, Maloney TM, McGrath CM: Evidence for a direct growth-stimulating effect of estradiol on human MCF-7 cells in vitro. Cancer Res 144: 2654-2659, 1987
15. Huff KK, Knabbe C, Lindsey R, Kaufman D, Bronzert D, Lippman ME, Dickson RB: Multihormonal regulation of insulin-like growth factor-1-related protein in MCF-7 human breast cancer cells. Mol Endocrinol 2: 200-208, 1988
16. Dickson RB, Huff KK, Spencer EM, Lippman ME: Introduction of epidermal growth factor related polypeptides by 17β-estradiol in MCF-7 human breast cancer cells. Endocrinol 118: 138-142, 1986
17. Katzenellenbogen BS, Kendra KL, Norman MJ, Berthois Y: Proliferation, hormonal responsiveness and estrogen receptor coment of MCF-7 human breast cancer cell growth in the short-term and long-term absence of estrogens. Cancer Res 47: 4355-4360, 1987
18. Petersen OW, Hoyer PE, van Deurs B: Frequency and distribution of estrogen receptor positive cells in normal, nonlactating human breast tissue. Cancer Res 47: 5748-5751, 1987
19. Jacquemier JD, Hassouin J, Torente M, Martin PM: Distribution of estrogen and progesterone receptors in healthy tissue adjacent to breast lesions at various stages: Immunohistochemical study of 107 cases. Breast Cancer Res Treat 15: 109-117, 1990
20. McGuire W, Carbone P, Vollmer R (eds): Estrogen Receptors in Human Breast Cancer. Raven Press, New York, 1975
21. Dickson R, Lippman M: Control of human breast cancer by estrogen, growth factors and oncogenes. In: Lipman ME, Dickson RB (eds) Estrogen Receptors in Human Breast Cancer. Raven Press, New York, 1975
22. Wittliff JL: Steroid-hormone receptors in breast cancer, Cancer 53: 630-643, 1984
23. Watts CKW, Handel ML, King RJB, Sutherland RL: Oestrogen receptor gene structure and function in breast cancer. J Steroid Biochem Molec Biol 41: 5293-5536, 1992
24. Aakvaag A, Utaacker E, Thorsen T, Lea OA, Lahooli H: Growth control of human mammary cancer cells (MCF-7 cells) in culture: Effect of estradiol and growth factors in serum containing medium. Cancer Res 50: 7806-7810, 1990
25. Dell'aquilla ML, Pigott DA, Bonaquist DL, Gaffney EV: A factor from plasma derived human serum that inhibits the growth of the mammary cell line MCF-7: Characterization and purification. J Natl Cancer Inst 72: 291-298, 1984
26. Kuiper GGJM, Enmark E, Pelto-Huikko M, Nilsson S, Gustaffson J-Å: Cloning of a novel estrogen receptor expressed in ral prostate and ovary. Proc Natl Acad Sci USA 93: 5925-5930, 1996
27. Byers M, Kuiper GGJM, Gustaffson J-Å, Park-Sarge OK: Estrogen receptor-β mRNA expression in rat ovary: Downregulation by gonadotropins. Mol Endocrinol 11: 172-182, 1997
28. Vladusic EA, Hornby AE, Guerra-Vladusic FK, Lupu R: Expression of estrogen receptor β messenger RNA variant in human breast cancer. Cancer Res 58: 210-214, 1998
29. Longacre TA, Bartow SA: A correlative morphologic study of human breast and endometrium in the menstrual cycle. Am J Surg Pathol 10: 382-393, 1986
30. Going JJ, Anderson TJ, Battersby S: Proliferative and secretory activity in human breast during natural and artificial menstrual cycles. Am J Pathol 130: 193-204, 1988
31. Potten CS, Watson RJ, Williams GT: The effeet of age and menstrual cycle upon proliferative activity of the normal human breast. Br J Cancer 58: 163-170, 1988
32. Clark RB, Howell A, Potter CS, Anderson E: Dissociation between steroid receptor expression and cell proliferation in the human breast. Cancer Res 57: 4987-4991, 1997
33. Laidlaw IJ, Clark RB, Howell A, Owen AWMC, Potten CS, Anderson E: Estrogen and progesterone stimulate proliferation of normal human breast tissue implanted in athymic nude mice. Endocrinol 136: 164-171, 1995
34. Clarke RB, Howell A, Anderson E: Estrogen sensitivity of normal human breast tissue in vivo and implanted into athymic nude mice; analysis of the relationship between estrogen-induced proliferation and progesterone receptor expression. Breast Cancer Res Treat 45: 121-183, 1997
35. Goodman HM: Basic Medical Endocrinology. Raven Press, New York, 1994, pp 288-290
36. Russo J, Russo IH: Influence of differentiation and cell kinetics on the susceptibility of the rat mammary gland to carcinogenesis. Cancer Res 40: 2677-2687, 1980
37. Russo J, Rivera R, Russo IH: Influence of age and parity on the development of the human breast. Breast Cancer Res Treat 23: 211-218, 1992
38. Russo J, Russo IH: Biology of disease. Biological and molecular bases of mammary carcinogenesis. Lab Invest 57: 112-137, 1987
39. Key G, Becket MH, Baron B, Duchrow M, Schluler C, Flad HD, Gerdes J: New Ki-67-equivalent murine monoclonal antibodies (MIB1-3) generated against bacterially expressed parts of the Ki-67 cDNA containing three 62 base pair repetitive elements encoding for the Ki-67 epitope. Lab Invest 68: 629-636, 1993
40. Haslam S: Role of sex steroid hormones in normal mammary gland function. In: Neville MC, Daniel CW (eds) The Mammary Gland: Development, Regulation and Function. Plenum Press, New York, 1987, pp 499-533
41. Clarke R, Dickson RB, Lippman ME: Hormonal aspects of breast cancer. Growth factors, drugs and stromal interactions. Crit Rev Oncol Hematol 12: 1-23, 1992
42. Knabbe C, Lippman ME, Wakefield LM, et al.: Evidence that transforming growth factor β is a hormonally regulated negative growth factor in human breast cancer cells. Cell 48: 417-428, 1987
43. Russo J, Reina D, Frederick J, Russo IH. Expression of phenotypical changes by human breast epithelial cells treated with carcinogens in vitro. Cancer Res 48: 2837-2857, 1998
44. Russo J, Calaf G, Russo IH: A critical approach to the malignant transformation of human breast epithelial cells. Crit Rev Oncogen 4: 403-417, 1993
45. Russo J, Gusterson BA, Rogers A, Russo IH, Wellings SR, van Zwieten MJ: Biology of breast disease. Comparative study of human and rat mammary tumorigenesis. Lab Invest 62: 244-278, 1990
46. Habel LA, Stamford JL: Hormone receptors and breast cancer. Epidemiol Rev 15: 209-219, 1993
47. Harlan LC, Coales RJ, Block G: Estrogen receptor status and dieting intakes in breast cancer patients. Epidemiology 4: 25-31, 1993
48. Moolgavkar SH, Day NE, Stevens RG: Two-stage model for carcinogenesis: Epidemiology of breast cancer in females. J Natl Cancer Inst 65: 559-569, 1980
49. Kodama F, Green GL, Salmon SE: Relation of estrogen receptor expression to clonal growth and antiestrogen effects on human breast cancer cells. Cancer Res 45: 2720-2724, 1985
50. Podhajcer OL, Bravo AL, Sorin I, Guman N, Cerdeiro R, Mordoh J: Determination of DNA synthesis, estrogen receptors, and carcinoembryonic antigen in isolated cellular subpopulations of human breast cancer. Cancer 58: 720-729, 1986
51. Hu, YF, Lau KM, Ho SM, Russo J: Increased expression of estrogen receptor β in chemically transformed human breast epithelial cells. Int J Oncol 12: 1225-1228, 1998
52. Foster JS, Wimalasena J: Estrogen regulates activity of cyclin-dependent kinases and retinoblastoma protein phosphorylation in breast cancer cells. Mol Endocrinol 10: 488-498, 1996
53. Wang W, Smith R, Burghardt R, Safe SH: 17β estradiol-mediated growth inhibition of MDA-MB 468 cells stably transfected with the estrogen receptor: Cell cycle effects. Mol Cell Endocrinol 133: 49-62, 1997
54. Levenson AS, Jordan VC: Transfection of human estrogen receptor (ER) cDNA into ER negative mammalian cell lines. J Steroid Biochem Mol Biol 51: 229-239, 1994
55. Weisz A, Bresciani F: Estrogen regulation of protooncogenes coding for nuclear proteins. Crit Rev Oncogen 4: 361-388, 1993
56. Zajchowski DA, Sager R, Webster L: Estrogen inhibits the growth of estrogen receptor negative, but not estrogen receptor positive, human mammary epithelial cells expressing a recombinant estrogen receptor. Cancer Res 53: 5004-5011, 1993
57. Pilat MJ, Christman JK, Brooks SC: Characterization of the estrogen receptor transfected MCF-10A breast cell line 139B6. Breast Cancer Res Treat 37: 253-266, 1996
58. Calaf G, Tahin Q, Alvarado MF, Estrada S, Cox T, Russo J: Hormone receptors and cathepsin D levels in human breast epithelial cells transformed by chemical carcinogens. Breast Cancer Res Treat 29: 169-177, 1993
59. Aronica SM, Kraus WL, Katzenellenbogen BS: Estrogen action via the cAMP signaling pathway. Stimulation of adenylate cyclase and cAMP regulated gene transcription. Proc Natl Acad Sci USA 91: 8517-8521, 1994
60. Pappos TC, Gametahu B, Watson CS: Membrane estrogen receptors identified by multiple antibody labeling and impeded-ligand binding. FASEB J 9: 404-410, 1994